Pherecydes Pharma s Phage Production Project (PhagoPROD) Featured in the European Commission s CORDIS Magazine
Regulatory News:
Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that its PhagoPROD project, partly funded by the European Commission, has been featured in CORBIS magazine. To read the article, please click on this link
CORBIS is the European Commission magazine highlighting the most strategic Research and Development projects financed by the European Union (EU).
PhagoPROD is one of the elements of Pherecydes Pharma s development that benefits from Horizon 20/20 funding enabling the Company to implement all the production procedures required to produce phages in accordance with Good Manufacturing Practices (GMP). These high pharmaceutical quality phages are necessary to launch clinical trials and make them available to medica
Cardinal Health Inks $1B Deal To Sell Cordis Business yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
January 2021 1041 Cordis, Hangzhou, Sci-Tech City opens and joins its sister Cordis hotels in Shanghai, Beijing, Dongqian Lake, Hong Kong and Auckland. Located in the heart of the high technological and integrated complex, Hangzhou Future Sci -Tech City, Cordis, Hangzhou is a contemporary, approachable luxury hotel which features 186 rooms and suites ranging from 36 to 190-sq-m in size, three restaurants and bar, a 24 hour well-equipped gym and a diverse range of flexible meeting and event spaces suitable for all events. Strategically located, the hotel is 400 meters away from Liangmulu subway station (Subway Line 5) and also have easy access to Alibaba’s headquarter, Xixi Tech Zone, Xixi Wetland National Park, Liangzhu Ancient City and West Lake.